Scotiabank Estimates Albemarle’s FY2026 Earnings (NYSE:ALB)

Albemarle Corporation (NYSE:ALB) – Scotiabank lowered their FY2026 earnings per share (EPS) estimates for Albemarle in a research note issued on Tuesday, February 17th. Scotiabank analyst B. Isaacson now anticipates that the specialty chemicals company will earn $8.38 per share for the year, down from their prior forecast of $9.57. Scotiabank has a “Sector Outperform” rating and a $200.00 price objective on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share. Scotiabank also issued estimates for Albemarle’s FY2027 earnings at $9.96 EPS.

Albemarle (NYSE:ALB) last posted its quarterly earnings data on Wednesday, February 11th. The specialty chemicals company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.13). Albemarle had a positive return on equity of 0.41% and a negative net margin of 10.74%.The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same quarter in the previous year, the firm posted ($1.09) earnings per share. The company’s quarterly revenue was up 15.9% on a year-over-year basis.

Other analysts also recently issued reports about the company. JPMorgan Chase & Co. cut their target price on Albemarle from $195.00 to $145.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. Argus upped their price objective on shares of Albemarle from $120.00 to $140.00 and gave the company a “buy” rating in a report on Monday, November 17th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Albemarle in a research note on Monday, December 29th. UBS Group boosted their target price on shares of Albemarle from $185.00 to $205.00 and gave the company a “buy” rating in a report on Monday, January 12th. Finally, Robert W. Baird set a $210.00 price target on shares of Albemarle and gave the stock an “outperform” rating in a report on Wednesday, January 7th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $167.52.

Albemarle Stock Down 0.0%

NYSE ALB opened at $168.33 on Thursday. The business has a fifty day moving average price of $161.88 and a 200 day moving average price of $118.49. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.57 and a current ratio of 2.23. The company has a market cap of $19.84 billion, a P/E ratio of -29.28, a P/E/G ratio of 1.76 and a beta of 1.44. Albemarle has a one year low of $49.43 and a one year high of $195.68.

Hedge Funds Weigh In On Albemarle

A number of large investors have recently modified their holdings of the business. MH & Associates Securities Management Corp ADV purchased a new stake in Albemarle during the fourth quarter worth $26,000. Elyxium Wealth LLC purchased a new stake in shares of Albemarle in the 4th quarter worth about $34,000. Torren Management LLC purchased a new stake in shares of Albemarle in the 4th quarter worth about $38,000. Root Financial Partners LLC grew its stake in Albemarle by 121.5% in the 4th quarter. Root Financial Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $42,000 after acquiring an additional 164 shares during the last quarter. Finally, Strategic Advocates LLC purchased a new position in Albemarle during the 3rd quarter valued at about $25,000. 92.87% of the stock is owned by hedge funds and other institutional investors.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.